Trial of an aromatic retinoid in patients with solid tumours.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000556:secondary; D005050:Etretinate / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D013724:Teratoma / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D014212:Tretinoin / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D014212:Tretinoin; D005050:Etretinate